Glaucoma is one of the leading causes of blindness.

The visual loss in glaucoma is the result of damage to the optic nerve, which connects the eye to the brain so we can see light, colors and objects.

Untreated glaucoma with uncontrolled eye pressure can cause the death of cells in the optic nerve, diminished peripheral vision and eventually blindness.

As of February 2022, a total of 37 states, the District of Columba, Guam, Puerto Rico and the U. S. Virgin Islands have legalized marijuana for medical uses, including treatment of glaucoma.

There is a lot of information regarding the health benefits of marijuana online and in the social media.

It is difficulty to sort out the truth from fiction.

Cannformatics, an early-stage biotechnology startup, has identified 22 new potential lipid-based Cannabis-Responsive biomarkers in the saliva of children with autism spectrum disorder (ASD).

The Biomarkers

A small percentage of Canadian nephrologists reported prescribing cannabis for chronic kidney disease management, according to data published in Kidney Medicine.

Further, nephrologists reported that the legalization of medical cannabis in 2018 did not have a great impact on their practice or prescriptions.

“Given the paucity of evidence regarding the safety or efficacy of cannabis in CKD, understanding current attitudes and practicing patterns of nephrologists is critical,” Kevin Gitau, MD, from the division of general internal medicine at St. Michael’s Hospital of Unity Health Toronto at the University of Toronto in Canada, and colleagues wrote.

Israeli study shows a combination of cannabis and mushrooms can kill a majority of colon cancer cells.

According to statistics, there are going to be over 106,000 new cases of colon cancer that going to be diagnosed this year alone.

Cases of colon cancer have been increasing steadily in the United States since the 1990’s especially among young adults, as this disease usually afflicts the elderly. Generally speaking, the survival rate for colon cancer survivors is just 64% but if it’s diagnosed in a localized stage, the prognosis increases significantly to 91%.

There is a dire need to develop more advanced medical solutions to address the growing colon cancer cases in order to save lives.

The Schizophrenia Society of Canada is pleased to announce the launch of Cannabis and Mental Health, a comprehensive online suite of digital resources exploring a range of issues surrounding the mental health impacts of cannabis, at the individual, community and societal level. This platform includes a free 90 minute course for youth, and created by youth, as well as a mentor guide with activities for educators, peer support workers, parents and youth allies.

This youth-led project was created in collaboration with Cannabis and Psychosis: Exploring the Link, the Youth Research and Evaluation Exchange (YouthREX), and the Mental Health Commission of Canada, with funding from Health Canada’s Substance Use and Addictions Program.

With cannabis accessibility on the rise, it’s more important than ever that consumers and patients also gain access to objective, evidenced-based information on cannabis use and health concerns.

Although there is limited data to support the use of cannabis as a first-line treatment in cancer-related symptoms, many patients are consuming it to relieve the anxiety, pain, nausea and insomnia that often come with a cancer diagnosis and subsequent chemotherapy treatment.

In a 2021 study, 42% of breast cancer patients reported using cannabis for symptom relief. Seventy-eight (78%) percent were using it to help with pain, 70% were using it for sleep, 57% were seeking help with anxiety, and 46% were using it for nausea and vomiting.

Veriheal’s Anonymous National Survey Data Show Which Cannabis Product Categories Are Most Sought, Coupled With Patient Quality of Life Goals

Healthcare technology company Veriheal today announced findings from its annual Medical Cannabis Preference Report, a segmented survey of registered medical cannabis patients that illuminates which types of cannabis products are preferred by men and women and what product offerings patients most hope to see available in dispensaries.

GTA dispensary, House of Cannabis is committed to breaking down stigma for new users to try cannabis products

Did you know, seniors are the fastest growing demographic of cannabis consumers in Canada?

Shocking right? How many times have you tried to convince your parents or grandparents that cannabis products might actually be able to benefit them or potentially improve their daily quality of life, only to be shut down?

Luckily, these old stigmas and unrealistic ideas of what cannabis products are, or how they impact a person who uses them are starting to break down. House of Cannabis is committed to breaking down these stigmas even further, and providing quality cannabis education to everyone, even seniors.

Is weed a depressant? How to classify cannabis.

Are you looking for answers to the question, "is marijuana a depressant?" If you have ever felt sleepy or sedated after using cannabis, you might have wondered, “is weed a depressant?” This article answers the questions “what is a depressant?”, “is weed a depressant?”, and “is cannabis a CNS depressant?” We will also discuss whether weed is an upper or a downer, and why this is such a common question. If you want to know if marijuana is a depressant, read on!